Fosun International’s BioMarin Pharmaceuticals BMRN Stock Holding History

Fosun International’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,500	Closed	-$215	–	187
2020 Q4	$215	Sell	2,500 -2,500	-50%	-$198K	0.01%	182
2020 Q3	$380K	Sell	5,000 -6,000	-55%	-$607K	0.03%	141
2020 Q2	$1.34M	Buy	11,000 +6,000	+120%	+$596K	0.13%	74
2020 Q1	$412K	Hold	5,000	–	–	0.04%	127
2019 Q4	$428K	Hold	5,000	–	–	0.04%	160
2019 Q3	$342K	Sell	5,000 -92,650	-95%	-$7.14M	0.04%	175
2019 Q2	$8.21M	Hold	97,650	–	–	0.54%	30
2019 Q1	$8.57M	Buy	97,650 +7,700	+9%	+$714K	0.54%	28
2018 Q4	$7.56M	Buy	89,950 +9,000	+11%	+$856K	0.45%	31
2018 Q3	$7.93M	Buy	+80,950	New	+$8.08M	0.38%	32

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fosun International's BMRN Position: Q1 2021 in Review

Fosun International sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2021, closing a stake of 2,500 shares — an estimated $215 sold.

Fosun International first reported a position in BMRN in Q3 2018 and held it in 10 quarters. The position peaked at $8.57M in Q1 2019. 530 funds tracked by Wall St. Rank hold BMRN as of Q1 2021.

Fosun International reported no remaining BioMarin Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Fosun International sold 2,500 BioMarin Pharmaceuticals shares in Q1 2021, an estimated $215.
Fosun International first reported a position in BioMarin Pharmaceuticals in Q3 2018 and held it in 10 quarters.
Fosun International's BioMarin Pharmaceuticals position peaked at $8.57M in Q1 2019.
530 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2021.

Based on Fosun International's 13F filing for Q1 2021, filed 11 May 2021.